Spencer D Proctor Selected Research

Apolipoprotein B-48

1/2021	ApoB-lipoprotein remnant dyslipidemia and high-fat meal intolerance is associated with markers of cardiometabolic risk in youth with obesity.
1/2020	ApoB48-remnant lipoproteins are associated with increased cardiometabolic risk in adolescents.
1/2018	Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin.
1/2016	Adiposity in Children and CVD Risk: ApoB48 Has a Stronger Association With Central Fat Than Classic Lipid Markers.
8/2010	Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome.
10/2002	Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Spencer D Proctor Research Topics

Disease

19	Obesity 01/2022 - 08/2007
16	Insulin Resistance 01/2022 - 06/2008
13	Cardiovascular Diseases (Cardiovascular Disease) 08/2020 - 10/2002
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2014 - 11/2006
10	Atherosclerosis 05/2014 - 10/2002
7	Inflammation (Inflammations) 01/2022 - 01/2010
7	Dyslipidemias (Dyslipidemia) 01/2021 - 11/2008
5	Hyperlipidemias (Hyperlipidemia) 04/2016 - 01/2012
4	Hypertrophy 01/2016 - 09/2008
3	Type 2 Diabetes Mellitus (MODY) 04/2016 - 10/2012
3	Neoplasms (Cancer) 03/2016 - 07/2011
3	Vascular Diseases (Vascular Disease) 03/2011 - 10/2007
2	Infarction (Infarctions) 12/2021 - 09/2012
2	Fibrosis (Cirrhosis) 01/2019 - 09/2016
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2017 - 05/2013
2	Non-alcoholic Fatty Liver Disease 07/2014 - 03/2014
2	Hyperinsulinism (Hyperinsulinemia) 12/2012 - 08/2010
2	Stroke (Strokes) 09/2012 - 08/2011
2	Chronic Disease (Chronic Diseases) 01/2012 - 03/2011
2	Glucose Intolerance 02/2011 - 10/2010
2	Body Weight (Weight, Body) 08/2010 - 11/2008
2	Sclerosis 08/2010 - 10/2007
2	Weight Gain 07/2010 - 10/2007
1	Dysbiosis 12/2021
1	Myocardial Infarction 12/2021
1	Morbid Obesity 12/2021
1	Hypertriglyceridemia 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Birth Weight (Birth Weights) 01/2019
1	Neoplasm Metastasis (Metastasis) 03/2016
1	Choline Deficiency 10/2015
1	Starvation 07/2014
1	Anorexia 07/2014
1	Hyperphagia (Overeating) 03/2014
1	Liver Failure 03/2014
1	Albuminuria 07/2013
1	Weight Loss (Weight Reduction) 05/2013
1	Fatty Liver 12/2012
1	Brain Injuries (Brain Injury) 09/2012
1	Ischemia 09/2012

Drug/Important Bio-Agent (IBA)

17	LipidsIBA 01/2021 - 09/2008
14	CholesterolIBA 12/2021 - 10/2002
13	Insulin (Novolin)FDA Link 01/2022 - 10/2007
11	Lipoproteins (Lipoprotein)IBA 01/2021 - 10/2002
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 11/2009
6	Apolipoprotein B-48IBA 01/2021 - 10/2002
6	11-octadecenoic acid (vaccenic acid)IBA 04/2016 - 01/2010
5	Apolipoproteins B (ApoB)IBA 01/2021 - 12/2012
5	ApolipoproteinsIBA 08/2020 - 10/2002
5	ChylomicronsIBA 01/2018 - 09/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2008
4	Choline (Choline Chloride)IBA 01/2022 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Conjugated Linoleic AcidsIBA 10/2013 - 07/2010
2	CytokinesIBA 01/2022 - 01/2010
2	Messenger RNA (mRNA)IBA 01/2019 - 08/2012
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018 - 06/2012
2	oxidized low density lipoproteinIBA 01/2017 - 09/2003
2	CeramidesIBA 06/2015 - 10/2010
2	Serine (L-Serine)FDA Link 06/2015 - 10/2010
2	Pharmaceutical PreparationsIBA 07/2014 - 03/2011
2	LDL Receptors (LDL Receptor)IBA 03/2014 - 09/2003
2	Simvastatin (Zocor)FDA LinkGeneric 01/2014 - 10/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	FatsIBA 12/2021
1	FructoseIBA 01/2019
1	Stearoyl-CoA DesaturaseIBA 01/2019
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	anandamide (arachidonylethanolamide)IBA 04/2016
1	C-PeptideIBA 04/2016
1	N-acylethanolaminesIBA 04/2016
1	AdipokinesIBA 01/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016
1	AdiponectinIBA 01/2016
1	Conditioned Culture MediaIBA 01/2016
1	LeptinIBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 06/2015
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 06/2015
1	Serotonin (5 Hydroxytryptamine)IBA 07/2014
1	Neuropeptide YIBA 03/2014
1	NeuropeptidesIBA 03/2014
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 03/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Fish OilsIBA 07/2013
1	AcidsIBA 07/2013
1	VLDL LipoproteinsIBA 12/2012
1	Carboxylesterase (Hydrolase S)IBA 12/2012
1	EsterasesIBA 12/2012
1	BiglycanIBA 10/2012
1	Ezetimibe (Zetia)FDA Link 10/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2012
1	Neuroprotective AgentsIBA 09/2012
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2012

Therapy/Procedure

1	Ligation 12/2021
1	Complementary Therapies (Alternative Medicine) 09/2016
1	Caloric Restriction 05/2013